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Purpose: Despite high amputation rates, data on patient-reported outcomes is scarce in the
elderly population with critical limb ischemia. The aim of this study was to provide mortality
rates and long-term changes of the following patient-reported outcomes in elderly critical
limb ischemia amputees: quality of life (QoL), health status (HS), and symptoms of
depression.
Patients and methods: In this prospective observational cohort study, amputated critical
limb ischemia patients ≥70 years were included. The follow-up period was two years. Within
the follow-up period patients completed the following questionnaires: the World Health
Organization Quality Of Life -abbreviated version of the WHOQOL 100 (WHOQOL-
BREF), the 12-Item Short Form Health Survey, and the Center for Epidemiological
Studies Depression Scale.
Results : A total of 49 elderly patients with critical limb ischemia had undergone major limb
amputation within two years after inclusion. In these patients, the one-year mortality rate was
39% and the two-year mortality rate was 55%. The physical QoL was the only domain of the
WHOQOL-BREF that improved significantly across time after amputation (p≤0.001). In the
long-term, there was no difference in the ability to enjoy life (p=0.380) or the satisfaction in
performing daily living activities (p=0.231) compared to the scores of the general elderly
population. After amputation, the physical HS domain (p≤0.001) and the mental HS domain
(p=0.002) improved. In the first year, amputees experienced less symptoms of depression
(p=0.004).
Conclusion: Elderly critical limb ischemia amputees are a fragile population with high
mortality rates. Their QoL and HS increased after major limb amputation as compared to the
baseline situation and they experienced less symptoms of depression. Moreover, our results
show that, in the long-term, major limb amputation in the elderly patients with critical limb
ischemia shows an acceptable QoL, which, in some aspects, is comparable to the QoL of
their peers. These results can improve the shared-decision making process that does not delay
the timing of major limb amputation.
Keywords: amputation, critical limb ischemia, frail elderly, health status, quality of life
Introduction
Critical limb ischemia is the most severe stage of peripheral arterial disease (PAD)
and is characterized by ischemic rest pain and/or tissue loss. In patients with critical
limb ischemia, the main goal of treatment is to salvage the affected limb.1,2 The
success of treatment for critical limb ischemia is measured by amputation free
survival (AFS).2 In order to achieve this desired outcome, patients with critical limb
ischemia are aggressively revascularized by endovascular or surgical procedures, if
possible.1,2 However, despite these efforts, amputation rates remain high. One year
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after the onset of critical limb ischemia, 25% of patients
will have to undergo a major limb amputation2,3 and
approximately 35–67% of critical limb ischemia patients
undergoes major limb amputation within four years.4
Moreover, early post-operative mortality rates range from
4% to 22% after major limb amputation from any cause.5
Early mortality rates of up to 20% are reported in critical
limb ischemia amputees.6,7
Because of high amputation and mortality rates func-
tional status and mobility success have been studied.8,9
Norvell et al and Taylor et al report that successful outcome
is associated with mobility capacity.8,9 However, mobility is
often impaired in elderly patients with critical limb ischemia.
This raises the question whether an assessment of objective
functioning, which is expected to be impaired, can be con-
sidered a good patient-reported outcome of treatment suc-
cess. Other patient-reported outcomes (PROs), such as
quality of life (QoL) and health status (HS), are increasingly
relevant in critical limb ischemia patients.10–12 QoL and HS
are supplementary, in the sense that HS questionnaires, like
the SF-12, focus on physical, psychological, and social
objective functioning and QoL questionnaires measure the
patients’ own satisfaction or evaluation of functioning.11,13,14
Furthermore, little is known about the QoL and HS of
critical limb ischemia amputees.15 The lack of literature on
long-term results is due to high mortality rates. Besides, the
absolute number of amputees per hospital is low.
Additionally, reports on changes in other mental health dis-
orders, like depression, after major limb amputation for
critical limb ischemia patients, is lacking in literature.16
Therefore, the aim of this prospective observational
cohort study was to provide short-term and long-term
changes of the following patient-reported outcomes in
elderly critical limb ischemia amputee patients: QoL, HS,
and symptoms of depression. The scores of specified World
Health Organization Quality Of Life -abbreviated version of
the WHOQOL 100 (WHOQOL-BREF) questions of the
elderly sample in the current study were compared to the
normal scores in the general elderly population. In addition,
the thirty-days, six-month, one-year and two-year mortality
rates of elderly critical limb ischemia patients after major
limb amputation will be addressed.
Methods
In this prospective observational cohort study, patients
with critical limb ischemia aged 70 years and older under-
going a major limb amputation, were included between
January 2012 and February 2016.17 Exclusion criteria
were a diagnosis of malignancy, lack of Dutch language
skills, or cognitive impairment. This study was conducted
in accordance with the Declaration of Helsinki. Based on
the criteria of the Central Committee on Research
Involving Human Subjects, a formal written waiver for
ethical approval was not required. The institutional medi-
cal ethical committee (AMOA) approved this. All patients
included signed an informed consent.
At a weekly multidisciplinary vascular conference, a
panel of experts placed the patients into one of four treat-
ment groups: surgical revascularisation, endovascular
revascularisation, conservative therapy, or major limb
amputation. During follow-up, secondary major limb
amputation was recorded. The follow-up period was two
years after inclusion.
Within this follow-up period patients completed the
following self-report questionnaires at six specified
times: WHOQOL-BREF, the 12-Item Short Form Health
Survey (SF-12), and the Center for Epidemiological
Studies Depression Scale (CES-D). Patients who under-
went major limb amputation during the 2-year follow-up
period were selected for this study. Questionnaires were
gathered that were completed six months, one year, and
between one-and-a-half years and two years after major
limb amputation.
WHOQOL-BREF
In the elderly, the validated WHOQOL-BREF question-
naire was utilized to measure QoL.18,19 This patient-com-
pleted measurement of health-related QoL is the short
version of the WHOQOL-100 and contains 26 items with
a 5-point Likert type response scale. These 26 questions
are grouped into four domains (physical health, psycholo-
gical health, social relationships, and environment) and a
general QoL facet. The WHOQOL-BREF is reliable and
valid instrument for measuring quality of life in the Dutch
adult population.10,18,20
SF-12
The SF-12 is a reliable and valid instrument for measuring
HS of the elderly population.21 The SF-12 is a shortened
version of the RAND 36-Item Short Form Health
Survey.22 The questionnaire consists of 12 questions with
three to five response levels, which are completed by
patients. It determines HS, which can be divided into the
Physical Component Summary (PCS) scale and the Mental
Component Summary (MCS) scale.10,22,23
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CES-D
Symptoms of depression were measured by means of the
CES-D questionnaire.24,25 In this study, the abbreviated
16-item version was applied, which is both widely used
and easy in use, especially in the elderly population.25 In
this questionnaire, patients were presented with 16 symp-
toms of depression and asked if they experienced any of
them. If they had experienced any of the sixteen symp-
toms, the frequency and duration within the past week was
asked to be noted. A CES-D cut off score of ≥12 specified
patients with symptoms of depression.26
Statistical analysis
Statistical analyses were done using a computerized software
package: SPSS version 23 (IBM, Chicago IL, USA).
Continuous and normally distributed variables were
expressed in terms of means and standard deviations.
Continuous and non-normally distributed variables were
expressed in terms of medians and interquartile ranges. The
Shapiro-Wilk test was used to assess whether continuous
variables were normally distributed. Categorical variables
were expressed in terms of frequencies and percentages.
Item-level missing data was imputed according to the guide-
lines of the particular questionnaire. Scale-level missing data
was directly handled through maximum likelihood estima-
tion, as implemented in the mixed modeling procedure.
Linear mixed models were used to assess the change of
QoL, HS, and symptoms of depression at three specified
times. Within mixed modeling, custom hypothesis tests
were used to assess differences between baseline and fol-
low-up measurements. Lastly, one sample t-tests were used
to compare the mean QoL estimates to corresponding esti-
mates in the general elderly population.27 A p-value of less
than 0.05 was considered significant.
Results
A total of 387 patients of 70 years or older were diagnosed
with critical limb ischemia during the inclusion period of
which 388 patients were excluded based on the criteria
previously stated. Two years after inclusion in this study, a
total of 49 elderly critical limb ischemia patients had under-
gone major limb amputation of the affected limb. These
patients were selected from a cohort initially treated with
surgical revascularisation (n=12), endovascular revascular-
isation (n=21), conservative therapy (n=11), or primary
major limb amputation (n=5). In Table 1, the patient char-
acteristics of all amputees are presented.
Table 1 Patient characteristics
Amputees
n=49 (100%)
Sex (male) 31 (64)
Median Age (IQR) 82 (75;84)
Living situation
– Independent* 23 (47)
– Home care 17 (35)
– Nursing facility 6 (12)
– Missing 3 (6)
Civil status
– Single 8 (16)
– Married or living with partner* 22 (45)
– Divorced 2 (4)
– Widowed* 14 (29)
– Missing 3 (6)
Educational level
– Low 20 (41)
– Middle 20 (41)
– High 6 (12)
– Missing 3 (6)
Currently smoking 10 (20)
Cardiac comorbidity 41 (84)
Neurologic comorbidity 17 (35)
Pulmonary comorbidity 36 (74)
Renal impairment 29 (59)
Arthrosis 9 (18)
Diabetes mellitus 27 (55)
Hypertension 31 (63)
Rutherford classification*
– Rutherford-class 4 8 (16)
– Rutherford-class 5/6 41 (84)
ASA classification
– ASA 2 9 (19)
– ASA 3 35 (71)
– ASA 4 5 (10)
Initially selected therapy
– Endovascular revascularization 21 (43)
– Surgical revascularization 12 (24)
– Conservative therapy 11 (23)
– Primary amputation 5 (10)
Previous minor amputation 13 (27)
Type of amputation
– Above knee amputation 15 (31)
– Through knee amputation 4 (8)
– Below knee amputation 30 (61)
Notes: Data are presented as n (%), unless otherwise specified. *Significant differ-
ence between age groups (p< 0.05).
Abbreviations: n, number of patients; IQR, interquartile range; ASA, American
Society of Anesthesiologists.
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Clinical outcome & mortality
Place of discharge is shown in Table 2. A small proportion
of patients (n=9, 18%) were able to go home after major
limb amputation. To the best of our knowledge, 17 ampu-
tees (35%) used a prosthesis at some point after major
limb amputation. The thirty-day mortality rate was 16%.
After 6 months, 31% of the amputees had deceased. The
one-year mortality rate was 39% and the two-year mortal-
ity rate increased to 55%.
Patient-reported outcome
Table 3 gives an overview of the median time between
amputation and the conduction of the CES-D, the
WHOQOL-BREF and the SF-12. As presented in Table 4,
the physical QoL was the only domain of the WHOQOL-
BREF that significantly improved in time, after amputation.
This improvement occurred at the 6-month measurement
compared with the baseline measurement (11.29 vs 14.44;
p≤0.001, 95% CI 1.61; 4.29) and remained significant after
1.5–2 years (11.29 vs 14.75; p≤0.001, 95% CI 2.49; 4.96).
There were no significant differences in time for the overall,
psychological, environmental, and social domains of the
WHOQOL-BREF. The SF-12 also showed improvement
in their physical HS domain, after 6 months compared
with the baseline measurement (29.73 vs 34.97; p=0.015,
95% CI 0.91; 7.82). This improvement remained significant
after 1.5–2 years compared with the baseline measurement
(29.73 vs 35.72; p≤0.001, 95% CI 3.02; 9.10). The mental
HS domain only showed a significant improvement after
1.5–2 years compared with the baseline measurement
(38.64 vs 44.46; p=0.002, 95% CI 3.88; 12.59). Amputee
patients experienced less symptoms of depression after
6 months (8.69 vs 4.45; p=0.004, 95% CI −5.91; −1.22)
and after 12 months (8.69 vs 4.56; p=0.004, 95% CI −6.62;
−1.40), compared with their baseline measurement.
Table 5 compares the scores of specified WHOQOL-
BREF questions at baseline and after amputation to nor-
mal scores in the general elderly population.27 While at
baseline the current elderly sample showed significantly
higher pain scores than the general elderly population
(mean Δ=0.769; p<0.001; 95% CI 0.47; 1.06), the pain
scores significantly improved and reached a level signifi-
cantly lower than the normal values of the elderly, both in
the short-term (mean Δ=−0.603; p=0.022; 95% CI −1.11;
−0.10) and in the long-term (mean Δ=−0.824; p=0.024;
95% CI −1.51; −0.13). Elderly critical limb ischemia
amputees were able to accept their bodily appearance
less, compared to the corresponding elderly. However,
their scores did not differ from their pre-amputation
scores. Overall, amputees rated their own quality of life
significantly lower than the corresponding elderly in the
long-term (mean Δ=−0.605; p=0.003, 95% CI −0.96;
−0.25). However in the long-term, there was no differ-
ence in the ability to enjoy life (mean Δ=0.145; p=0.380;
95% CI −0.21; 0.50), the amount of energy the elderly
had (mean Δ=−0.545; p=0.052; 95% CI −1.10; 0.01), or
the satisfaction in performing daily living activities
(mean Δ=−0.265; p=0.231; 95% CI −0.73; 0.20).
Discussion
PROs have become a very important outcome of treatment
in the elderly critical limb ischemia patients.10–12
Considering that a quarter of critical limb ischemia
patients undergo major limb amputation during the first
year after disease onset, there is a surprising lack of PROs
in the vascular amputees.15 Compared to other multicenter
studies, we assessed a relatively large number of critical
limb ischemia amputee patients, aged 70 and older, on
PROs and clinical outcomes in a prospective observational
cohort two-center study. A selection of questions from the
WHOQOL-BREF questionnaire, relevant for amputees,
was compared to the corresponding values of their elderly
peers.27
The main finding was that physical QoL and physical
HS significantly improved after amputation in elderly cri-
tical limb ischemia patients. Mental HS also improved but




– Home 9 (18)
– Nursing facility 16 (33)
– Inpatient rehabilitation 18 (37)
– Decease before discharge 3 (6)
– Missing 3 (6)
Notes: Data are presented as n and (%).
Table 3 Time to conduction of the questionnaires
n Median time IQR
Baseline 49
Half year 23 167 148–185
1 year 16 357 336.5–362.75
1.5–2 years 11 697 651–726
Note: Data presented as median.
Abbreviations: n, number of patients; IQR, interquartile range.
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only in the long-term. This study also demonstrated that
critical limb ischemia patients experienced less symptoms
of depression after amputation compared to baseline.
Mortality rates were also analysed. The one-year mortality
rate was 39% and two-year was 55%.
Reduced physical functioning and QoL characterize
critical limb ischemia patients.2 Therefore, one of the
goals of the treatment of critical limb ischemia is to
improve their physical function and QoL.2,28 Primary
major limb amputation, without an attempt at
Table 4 Patient-reported outcomes for amputees (n=49)
n Mean SD p-value 95% CI
WHOQOL-BREF overall QoL
Baseline 49 3.18 0.85
Half year 23 3.47 0.59 0.342 −0.1796; 0.4947
1 year 16 3.63 0.56 0.121 −0.0843; 0.6814
1.5–2 years 11 3.55 0.42 0.198 −0.1439; 0.6368
WHOQOL-BREF physical health
Baseline 49 11.29 2.67
Half year 23 14.44 2.33 ≤0.001 1.6123; 4.2901
1 year 16 14.46 2.34 ≤0.001 1.6320; 4.1622
1.5–2 years 11 14.75 1.86 ≤0.001 2.4949; 4.9603
WHOQOL-BREF Psychological health
Baseline 49 14.00 2.36
Half year 23 14.89 1.90 0.162 −0.2052; 1.1654
1 year 16 15.17 1.57 0.199 −0.3819; 1.7532
1.5–2 years 11 14.73 1.28 0.269 −0.3395; 1.1448
WHOQOL-BREF social relationships
Baseline 49 15.99 2.23
Half year 23 16.17 2.00 0.897 −0.7205; 0.8220
1 year 15 16.36 1.55 0.978 −0.9858; 0.9587
1.5–2 years 11 15.76 1.59 0.163 −1.7996; 0.3037
WHOQOL-BREF environment
Baseline 49 15.57 2.07
Half year 23 14.96 1.45 0.067 −1.3431; 0.0463
1 year 16 15.34 1.42 0.702 −0.8126; 0.5473
1.5–2 years 11 15.36 0.74 0.125 −1.0256; 0.1248
SF-physical
Baseline 48 29.73 9.36
Half year 23 34.98 6.54 0.015 0.9095; 7.8204
1 year 16 34.97 5.40 0.022 0.6319; 7.7767
1.5–2 years 11 35.72 4.77 ≤0.001 3.0249; 9.1026
SF-mental
Baseline 48 38.64 11.37
Half year 23 43.21 6.97 0.063 −0.2088; 7.69,795
1 year 16 43.66 8.55 0.262 −2.4686; 8.7032
1.5–2 years 11 44.46 9.07 0.002 3.8787; 12.5862
CESD
Baseline 48 8.69 7.05
Half year 22 4.45 4.72 0.004 −5.9119; −1.2185
1 year 16 4.56 3.44 0.004 −6.6151; −1.3993
1.5–2 years 11 5.00 4.90 0.050 −6.3459; 0.0027
Notes: Data presented as mean. A p-value<0 .05 is considered significant and is characterized by bold text.
Abbreviations: n, number of patients; SD, standard deviation; CI, confidence interval; WHOQOL-BREF, World Health Organization Quality Of Life -abbreviated version of
the WHOQOL 100; CESD, Center for Epidemiologic Studies Depression.
Dovepress Peters et al
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Table 5 WHOQOL-BREF compared to normal values for elderly
n Value Value of general elderly population27 Mean difference p-value 95% CI
Item 1. How would you rate your quality of life?
Very poor (1) – poor (2) – neither poor nor good (3) – good (4) – very good (5)
Baseline 49 3.33 4.06 −0.733 <0.001 −1.01; −0.46
Half year 22 3.27 −0.787 <0.001 −1.10; −0.48
1 year 17 3.65 −0.413 0.027 −0.77; −0.05
1.5–2 years 11 3.45 −0.605 0.003 −0.96; −0.25
Item 3. To what extend do you feel that physical pain prevents you from doing what you need to do?
Not at all (1) – a little (2) – a moderate amount (3) – very much (4) – an extreme amount (5)
Baseline 48 3.23 2.46 0.769 <0.001 0.47; 1.06
Half year 21 1.86 −0.603 0.022 −1.11; −0.10
1 year 16 1.56 −0.898 0.002 −1.41; −0.38
1.5–2 years 11 1.64 −0.824 0.024 −1.51; −0.13
Item 5. How much do you enjoy life?
Not at all (1) – a little (2) – a moderate amount (3) – very much (4) – an extreme amount (5)
Baseline 49 3.10 3.31 −0.208 0.083 −0.44; 0.03
Half year 22 3.48 0.166 0.360 −0.20; 0.54
1 year 17 3.35 0.043 0.852 −0.44; 0.52
1.5–2 years 11 3.45 0.145 0.380 −0.21; 0.50
Item 10. Do you have enough energy for everyday life?
Not at all (1) – a little (2) – moderately (3) – mostly (4) – completely (5)
Baseline 49 3.29 4.09 −0.804 <0.001 −1.10; −0.51
Half year 22 3.64 −0.454 <0.001 −0.67; −0.24
1 year 17 3.41 −0.678 <0.001 −1.00; −0.36
1.5–2 years 11 3.55 −0.545 0.052 −1.10; 0.01
Item 11. Are you able to accept you bodily appearance?
Not at all (1) – a little (2) – moderately (3) – mostly (4) – completely (5)
Baseline 48 3.77 4.36 −0.589 <0.001 −0.89; −0.29
Half year 22 3.86 −0.496 0.007 −0.84; −0.15
1 year 17 3.88 −0.478 <0.001 −0.65; −0.31
1.5–2 years 11 3.73 −0.633 0.024 −1.16; −0.10
Item 16. How satisfied are you with your ability to perform daily living activities?
Very dissatisfied (1) – dissatisfied (2) – neither satisfied nor dissatisfied (3) – satisfied (4) – very satisfied (5)
Baseline 49 2.88 3.81 −0.932 <0.001 −1.24; −0.63
Half year 22 3.18 −0.628 0.006 −1.05; −0.20
1 year 17 3.24 −0.575 0.018 −1.04; −0.11
1.5–2 years 11 3.55 −0.265 0.231 −0.73; 0.20
Item 18. How satisfied are you with yourself?
Very dissatisfied (1) – dissatisfied (2) – neither satisfied nor dissatisfied (3) – satisfied (4) – very satisfied (5)
Baseline 49 3.57 3.97 −0.399 0.002 −0.65; −0.15
Half year 22 3.82 −0.152 0.240 −0.41; 0.11
1 year 17 3.82 −0.146 0.270 −0.42; 0.13
1.5–2 years 11 3.73 −0.243 0.116 −0.56; 0.07
(Continued)
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revascularization, is not often performed because we
believe that these treatment goals cannot be achieved
with major limb amputation. Still, a large proportion of
critical limb ischemia patients must undergo secondary
major limb amputation at some point in the course of
their disease because of inadequate perfusion. Our cohort
shows that improved physical QoL and physical HS are
possible in the long-term. Moreover, the ability to enjoy
life, the amount of energy elderly patients had, and/or the
satisfaction in performing daily living activities is compar-
able to that of the Dutch elderly. Understandably, critical
limb ischemia amputee patients report less pain symptoms
than their peers. Still, these patients rate a poorer QoL and
poorer acceptance of bodily appearance in these specific
questions of the WHOQOL-BREF questionnaire.
However, their scores of the acceptance of bodily appear-
ance did not differ from their pre-amputation scores. In
terms of personalized medicine and shared-decision mak-
ing, it is important to understand the changes in the several
domains of the questionnaires in comparison with the
normal elderly population.
Suckow et al stated that QoL assessment in critical
limb ischemia patients should incorporate patient
preference.15 In this study, the WHOQOL-BREF question-
naire was used. Though a consensus still has to be reached
on a specific QoL measure for critical limb ischemia
amputee patients, the WHOQOL-BREF has the benefit of
taking patients’ evaluation or satisfaction with functioning
into consideration.14,27 Therefore, we argue that the
WHOQOL-BREF is an appropriate instrument to measure
QoL in critical limb ischemia amputee patients. In this
study, QoL did not deteriorate after major limb amputa-
tion. Even more so, patients indicated they were
significantly more satisfied with their physical QoL after
amputation compared with before amputation.
Other questionnaires, such as the SF-36, lack discrimi-
natory power in critical limb ischemia patients character-
ized by their many comorbidities.15,29,30 Since the SF-12 is
an abbreviated version of the SF-36; our results of HS
improvement, after major limb amputation, should be
interpreted with care. Still, the scores on the physical and
mental HS scale did not deteriorate after major limb
amputation. These results are in line with the amputee
placebo group of Peeters et al in their study investigating
the effect on HS of bone marrow derived mononuclear cell
administration in critical limb ischemia patients without
treatment options.31
The prevalence of depression in PAD patients has a
range between 3% and 48%.32 Arya et al and McDermott
et al stated that depression in PAD patients leads to a
significantly higher risk of mortality.16,33 Moreover, Arya
et al described an increased amputation rate in PAD
patients with symptoms of depression.16 A review on
depression in amputees, from varying etiologies, con-
cluded that depression rates are relatively high up to
2 years after major limb amputation.34 However, little is
known about depression after major limb amputation due
to critical limb ischemia in the elderly alone.35 Our study
demonstrated that critical limb ischemia patients experi-
enced less symptoms of depression after major limb ampu-
tation. A possible explanation for the decrease in scores of
symptoms of depression can be the relief of ischemic rest
pain in the limb after major limb amputation in the elderly
critical limb ischemia patients. So, from a mood-disorder
point of view, improved outcome is possible with major
limb amputation. Therefore, screening for symptoms of
Table 5 (Continued).
n Value Value of general elderly population27 Mean difference p-value 95% CI
Item 25. How well are you able to get around?
Very poor (1) – poor (2) - neither poor nor good (3) – good (4) – very good (5)
Baseline 47 2.49 3.70 −1.211 <0.001 −1.56; −0.87
Half year 22 3.32 −0.382 0.058 −0.78; 0.01
1 year 17 3.53 −0.171 0.433 −0.62; 0.28
1.5–2 years 11 3.36 −0.366 0.255 −0.96; 0.28
Notes: Data presented as mean; The value of the general elderly population is based on reference 27. One sample t-tests were used to compare the mean QoL estimates to
corresponding estimates in the general elderly population. A p-value of <0.05 is considered significant and is characterized by bold text.
Abbreviations: n, number of patients; CI, confidence interval; QoL, quality of life; WHOQOL-BREF, World Health Organization Quality Of Life -abbreviated version of the
WHOQOL 100.
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depression is important to complement the shared-decision
making process in elderly critical limb ischemia patients.
In patients undergoing major limb amputation, from any
cause, mortality rates are extremely high. The 30-day mor-
tality rates and the in-hospital mortality rates range between
4% and 22%.5 After 1 year, mortality rates in critical limb
ischemia patients are even higher; up to 44% in patients
aged 70 or older.7,36–39 Within 2 years’ time, 1 in 2 patients
will have deceased after major limb amputation.7,38,39 Our
results are in line with these previously mentioned studies.
The 30-day mortality rate was 16%, one-year was 39% and
two-year was 55%. These high mortality rates raise the
question of what outcome is more important to achieve
after major limb amputation. Along this line, one should
consider patients who may benefit from having an earlier
major limb amputation. Shared-decision making concern-
ing this topic is important, since each patient may value his/
her limb salvage differently.
Clearly, this study has limitations. First, the sample
size of critical limb ischemia amputee patients decreases
over time. Due to high mortality rates in this particular
patient population, the sample size can be considered
fairly large for a two-center study and also compared to
other studies. However, attrition due to mortality could
have biased our conclusions. Secondly, symptoms of
depression were measured by self-report questionnaires.
Self-report questionnaires are not yet part of standard
care. The gold standard in diagnosing depression is the
use of diagnostic interviews.40,41 However, if one wants to
assess symptoms of depression quickly in routine care, the
CES-D questionnaire is a frequently used and accurate
instrument in elderly patients.42 Third, because there was
no control group to compare the amputees to, any changes
in QoL, HS and depression following amputation can be
confounded by other factors not related to the intervention,
such as spontaneous recovery.
Conclusion
Elderly critical limb ischemia amputee patients are a fra-
gile population with high short and long-term mortality
rates. In this study, we concluded that QoL and HS did not
diminish after major limb amputation, neither in the short-
term or the long-term. Moreover, our results show that
major limb amputation in the elderly critical limb ischemia
patients in the long term gives an acceptable QoL, which,
in some aspects, is comparable to the QoL of their peers.
Individual treatment goal setting plays an important role
when undergoing hospital care, especially in elderly
patients. In order to accomplish a good shared-decision
making process that does not delay the timing of major
limb amputation, patients and family should not only be
informed about the mortality rates but also about the fact
that QoL and HS does not seem to diminish in critical limb
ischemia amputees, aged 70 and older, in the long-term.
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